Surrogate markers for the prediction of long-term outcome in transplantation: Nantes Actualité Transplantation (NAT) 2007 Meeting Report

Human Immunology

Volumn 69, Issue 1, 2008, Pages 2-8

  Brouard, Sophie ^a,b,c   Ashton Chess, Joanna ^a,b,c   Soulillou, Jean Paul ^a,b,c  

^a INSERM   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LEUKOCYTE ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3;

BIOPSY TECHNIQUE; CONFERENCE PAPER; DISEASE MARKER; GENE EXPRESSION PROFILING; GENETIC POLYMORPHISM; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEOMICS;

BIOLOGICAL MARKERS; ENDPOINT DETERMINATION; GENE EXPRESSION PROFILING; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; POLYMORPHISM, GENETIC; PROTEOMICS; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

EID: 39549121784     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2007.11.004     Document Type: Conference Paper

References (16)

1. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther 69 (2001) 89
2. Lederer S.R., Kluth-Pepper B., Schneeberger H., Albert E., Land W., and Feucht H.E. Impact of humoral alloreactivity early after transplantation on the long-term survival of renal allografts. Kidney Int 59 (2001) 334
3. Anglicheau D., Loupy A., Suberbielle C., Zuber J., Patey N., Noël L.H., et al. Posttransplant prophylactic intravenous immunoglobulin in kidney transplant patients at high immunological risk: A pilot study. Am J Transplant 7 (2007) 1185
4. Lipman M.L., Shen Y., Jeffery J.R., Gough J., McKenna R.M., Grimm P.C., and Rush D.N. Immune-activation gene expression in clinically stable renal allograft biopsies: Molecular evidence for subclinical rejection. Transplantation 66 (1998) 1673
5. Dahan K., Audard V., Roudot-Thoraval F., Desvaux D., Abtahi M., Mansour H., et al. Renal allograft biopsies with borderline changes: Predictive factors of clinical outcome. Am J Transplant 6 (2006) 1725
6. Nankivell B.J., Borrows R.J., Fung C.L., O'Connell P.J., Allen R.D., and Chapman J.R. The natural history of chronic allograft nephropathy. N Engl J Med 349 (2003) 2326
7. Martinez-Llordella M., Puig-Pey I., Orlando G., Ramoni M., Tisone G., Rimola A., et al. Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 7 (2007) 309
8. Brouard S., Mansfield E., Braud C., Li L., Giral M., Hsieh S.C., et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci U S A 25 (2007) 104
9. Deng M.C., Mehra M.R., Billingham M., Marboe C.C., Berry G., Kobashigawa J., et al., CARGO Investigators. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. EH. Am J Transplant 6 (2006) 150
10. Kurian S.M., Flechner S.M., Kaouk J., Modlin C., Goldfarb D., Cook D.J., et al. Laparoscopic donor nephrectomy gene expression profiling reveals upregulation of stress and ischemia associated genes compared with control kidneys. Transplantation 80 (2005) 1067
11. Kainz A., Perco P., Mayer B., Soleiman A., Steininger R., Mayer G., et al. Gene-expression profiles and age of donor kidney biopsies obtained before transplantation distinguish medium term graft function. Transplantation 83 (2007) 1048
12. Flechner S.M., Kurian S.M., Head S.R., Sharp S.M., Whisenant T.C., Zhang J., et al. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 4 (2004) 1475
13. Donauer J., Rumberger B., Klein M., Faller D., Wilpert J., Sparna T., et al. Expression profiling on chronically rejected transplant kidneys. Transplantation 76 (2003) 539
14. Mas V., Maluf D., Archer K., Yanek K., Mas L., King A., et al. Establishing the molecular pathways involved in chronic allograft nephropathy for testing new noninvasive diagnostic markers. Transplantation 83 (2007) 448
15. Ducloux D., Deschamps M., Yannaraki M., Ferrand C., Bamoulid J., Saas P., et al. Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int 67 (2005) 2454
16. Sawitzki B., Bushell A., Steger U., Jones N., Risch K., and Siepert A. Identification of gene markers for the prediction of allograft rejection or permanent acceptance. Am J Transplant 7 (2007) 1091